PatternsRadar
Sign in

WOCKPHARMAWockhardt Limited

NSE
Full chart
2,176.40INR+112.90 (+5.47%)Close · 6 Oct 2026
10 Aug 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹35,365 CrMarket cap
85.4P/E (TTM)
36.1%Delivery

Filings & corporate actions

82 results filed
CSV
Next results · Q2 FY27
Expected 3 Nov 2026 – 14 Nov 2026
Estimate: filed 34–45 days after quarter end, last 5 times
Dividend
₹10.00 per share · last 17 Nov 2016
2026
  • 10 AugresultsResults · Q1 FY27 · consolidated and standalone-1.1%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026-1.4%NSE
  • 4 MayresultsResults · Q4 FY26 · consolidated and standalone+7.9%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.6%NSE
  • 10 FebresultsResults · Q3 FY26 · consolidated and standalone+1.3%NSE
  • 19 JanshareholdingShareholding · 31 Dec 2025-0.7%NSE

Reaction to results · all yearsrose on day 0 in 31 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY2710 Aug 2026-1.1%-3.7%+15.2%1.6×
Q4 FY264 May 2026+7.9%+10.2%+45.5%27.4×
Q3 FY2610 Feb 2026+1.3%-1.1%-7.5%4.8×
Q2 FY263 Nov 2025-3.4%-3.8%+0.1%1.4×
Q1 FY268 Aug 2025-0.6%+1.4%+6.0%0.9×
Q4 FY2529 May 2025+8.8%+11.8%+21.8%6.0×
Q3 FY257 Feb 2025-3.1%-16.1%-23.7%1.0×
Q2 FY2513 Nov 2024-1.6%+8.9%+28.7%0.8×
Q1 FY259 Aug 2024+3.0%+2.8%+8.8%2.4×
Q4 FY2428 May 2024+0.6%-7.1%+16.9%2.2×
Q3 FY2414 Feb 2024-1.0%+26.4%+16.0%0.6×
Q2 FY2414 Nov 2023-1.5%+16.5%+42.4%4.6×
Q1 FY2414 Aug 20230.0%-4.6%+3.3%0.4×
Q4 FY2326 May 2023-1.7%-2.3%+34.5%0.6×
Q3 FY2313 Feb 2023-2.6%+0.4%-10.9%1.3×
Q2 FY234 Nov 2022-0.1%-0.9%-4.6%0.7×
Q1 FY2312 Aug 2022-2.3%+8.2%+16.6%1.1×
Q4 FY2231 May 2022+2.4%-0.7%-18.9%0.5×
Q3 FY2227 Jan 20220.0%+0.2%-13.6%0.5×
Q2 FY229 Nov 2021+1.1%-1.3%-6.3%1.2×
Q1 FY2222 Jul 2021-0.4%-3.8%-22.2%0.5×
Q4 FY2128 May 2021-2.4%-2.9%-16.2%0.8×
Q3 FY2129 Jan 2021+0.6%+5.5%+4.0%0.5×
Q2 FY213 Nov 2020-1.6%-2.1%+50.0%1.6×
Q1 FY2129 Aug 2020-5.0%-9.7%-14.7%0.7×
Q4 FY2011 May 2020-4.9%-17.0%+1.1%1.4×
Q3 FY2027 Jan 2020-2.1%-2.7%-3.9%5.9×
Q2 FY208 Nov 2019+0.2%+0.7%-16.7%0.5×
Q1 FY2014 Aug 2019-2.2%-11.7%+11.4%0.8×
Q4 FY1924 May 2019-0.2%-2.1%-5.1%0.6×
Q3 FY1929 Jan 2019+0.9%-7.6%-12.0%1.4×
Q2 FY1919 Nov 2018-2.6%-1.9%-1.2%0.7×
Q1 FY1924 Aug 2018-1.9%+1.5%-13.9%0.8×
Q4 FY1825 May 2018+1.9%-4.2%-2.1%0.6×
Q3 FY1810 Feb 2018+0.8%-5.7%-1.8%0.8×
Q2 FY181 Nov 2017+0.5%+10.2%+10.4%0.9×
Q1 FY184 Aug 20170.0%-5.8%+2.1%0.6×
Q4 FY1716 Jun 2017-6.7%-7.3%-1.2%3.7×
Q3 FY1725 Jan 2017-3.1%-2.5%+3.2%1.3×
Q2 FY1714 Nov 2016-3.0%-12.1%-12.0%0.9×
Q1 FY1728 Sept 2016-4.5%-0.5%-3.7%2.5×
Q4 FY1610 May 2016-1.4%-0.4%-0.1%0.6×
Q3 FY1613 Feb 2016-0.5%+6.4%+28.3%2.5×
Q2 FY1616 Nov 2015+0.3%+5.5%+3.0%0.8×
Q1 FY1611 Aug 20150.0%+1.2%-28.2%1.2×
Q4 FY1529 May 2015+2.0%-9.1%-4.4%0.6×
Q3 FY155 Feb 2015-3.7%+16.4%+31.9%2.4×
Q2 FY157 Nov 2014+4.3%+4.5%+34.0%2.0×
Q1 FY1519 Aug 2014+1.7%+0.7%+21.0%0.7×
Q4 FY1427 May 2014-4.5%-14.9%-19.7%0.8×
Q3 FY1410 Feb 2014+3.5%-1.9%+10.1%2.3×
Q2 FY143 Nov 2013-1.5%+6.0%-11.2%0.4×
Q1 FY1422 Aug 2013-1.4%+7.7%+36.6%0.7×
Q4 FY1310 Jun 2013-10.0%-7.3%-24.0%0.2×
Q3 FY1320 Feb 2013+1.3%+2.5%+3.4%1.2×
Q2 FY1316 Nov 2012-2.1%+0.7%-9.5%0.6×
Q1 FY137 Aug 2012+2.4%+17.5%+21.2%1.3×
Q4 FY1223 May 2012+12.7%+11.5%+23.2%17.4×
Q3 FY1213 Feb 2012+4.7%+10.5%+28.4%6.0×
Q2 FY1217 Nov 2011+0.2%-2.0%-21.4%1.0×
Q1 FY129 Aug 2011-5.9%-13.8%-12.0%2.0×
Q4 FY1119 May 2011+5.6%+0.9%+9.8%7.9×
Q3 FY112 Feb 2011+5.0%-8.4%-8.6%5.2×
Q2 FY1112 Nov 2010+10.8%+7.3%-4.9%4.7×
Q1 FY1113 Aug 2010+17.6%+52.7%+72.1%12.3×
Q3 FY1025 Jan 2010-4.3%-2.3%-15.6%0.6×
Q2 FY1031 Oct 2009-5.1%+5.8%+3.7%1.2×
Q1 FY1030 Jul 2009-4.7%-1.4%+10.1%1.1×
Q3 FY0924 Apr 2009-5.4%-14.1%+19.3%0.4×
Q4 FY0924 Apr 2009-5.4%-14.1%+19.3%0.4×
Q2 FY0921 Oct 2008+0.8%-11.9%-36.1%1.1×
Q1 FY0928 Jul 2008-2.5%+1.5%+3.9%0.8×
Q4 FY0828 Apr 2008-2.4%-0.2%-4.2%3.1×
Q3 FY0820 Feb 2008-1.4%-4.2%-27.0%0.6×
Q2 FY0823 Oct 2007+0.6%-0.2%-3.3%3.5×
Q1 FY0825 Jul 2007+3.3%-2.4%-4.5%2.0×
Q4 FY0726 Apr 2007-2.3%-4.3%-1.6%0.9×
Q3 FY0722 Feb 2007+0.8%+13.4%+16.0%2.9×
Average-0.2%+0.3%+3.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+25.9%
Profit YoY—
Interest cost YoY-5.2%
Revenue QoQ-3.7%
Profit QoQ-34.8%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+11.0%+9.7%+4.7%+3.7%+3.2%-1.7%
Profit————-9.5%—

Key data

CSV
Open2,067.20
Day range2,062.00 – 2,184.00
52-week range1,086.70 – 2,422.30
From 52w high-10.2%
RSI (14)54.9
ATR (14)94.38
Volume8.99L
Avg volume (20D)12.75L
Rel volume0.71×
Volatility (1Y)48.2%
Turnover₹195.7Cr
SMA 50 / 2002,022.52 / 1,659.83

Delivery percentage

Latest · 6 Oct 202636.1%
20-day avg34.0%
1-year avg37.0%
Percentile (own history)47th
Range6.0–100.0%
Sessions1,731

Over the last 20 sessions WOCKPHARMA settled 34.0% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 37.0%, so recent sessions are running 3.1 points lower than usual. The latest session ranks higher than 47% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMADRREDDYMOREPENLABZYDUSLIFE

Performance returns

CSV
1D1W1M3M6M1Y
Price+5.47%-0.51%+11.58%+17.17%+71.17%+62.84%

Valuation

CSV
Market cap₹35,365 Cr
P/E (TTM)85.4
EPS (TTM)25.48
Shares outstanding16.20Cr
Listed23 Feb 2000

Ownership

CSV
Promoter49.08%
Promoter Δ QoQ0.00 pp
Public50.92%
FII7.22%
DII9.24%
Pledged14.68%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)782.0888.0965.0929.0
YoY chg-3.3%+23.2%+29.9%+25.9%
Net profit (₹ Cr)82.061.0164.0107.0
YoY chg—+205.0%——
Net margin10.5%6.9%17.0%11.5%
EPS4.813.6110.226.55

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 49.08% · public 50.92%
30 Sept 2021: promoter 68.04%31 Dec 2021: promoter 67.13%28 Mar 2022: promoter 67.13%31 Mar 2022: promoter 67.13%30 Jun 2022: promoter 65.75%30 Sept 2022: promoter 63.83%31 Dec 2022: promoter 60.36%31 Mar 2023: promoter 59.31%30 Jun 2023: promoter 58.40%30 Sept 2023: promoter 55.14%31 Dec 2023: promoter 54.93%26 Mar 2024: promoter 51.60%31 Mar 2024: promoter 51.60%30 Jun 2024: promoter 51.99%30 Sept 2024: promoter 51.99%11 Nov 2024: promoter 49.09%31 Dec 2024: promoter 49.09%31 Mar 2025: promoter 49.09%30 Jun 2025: promoter 49.09%30 Sept 2025: promoter 49.08%31 Dec 2025: promoter 49.08%31 Mar 2026: promoter 49.08%30 Jun 2026: promoter 49.08%
2021-092026-06
  • Promoter
  • Public and others
Promoter
49.08%
Public
50.92%
Promoter change
0.00 pp
Filed
21 Jul 2026
FII
7.22%
DII
9.24%
Promoter pledged
14.68%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations753.0701.0700.0739.0809.0721.0743.0738.0782.0888.0965.0929.0
Other income24.08.054.030.09.08.015.020.021.025.045.031.0
Total income777.0709.0754.0769.0818.0729.0758.0758.0803.0913.01,010.0960.0
Total expenses812.0796.0934.0775.0827.0708.0780.0770.0712.0836.0843.0844.0
└ Finance costs76.077.073.073.073.060.048.048.055.060.050.052.0
└ Depreciation55.055.058.054.055.055.053.056.053.065.053.055.0
Profit before tax(35.0)(87.0)(180.0)(6.0)(9.0)21.0(22.0)(109.0)91.067.0189.0116.0
Tax expense38.0(1.0)(3.0)10.07.01.023.0(1.0)9.06.025.09.0
Net profit(73.0)(86.0)(177.0)(16.0)(16.0)20.0(45.0)(108.0)82.061.0164.0107.0
EPS-5.37-5.75-11.64-0.95-1.470.91-1.57-5.534.813.6110.236.55
Net margin-9.69%-12.27%-25.29%-2.17%-1.98%2.77%-6.06%-14.63%10.49%6.87%16.99%11.52%
PBT margin-4.65%-12.41%-25.71%-0.81%-1.11%2.91%-2.96%-14.77%11.64%7.55%19.59%12.49%
Tax rate—————4.76%——9.89%8.96%13.23%7.76%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 10 Aug 2026.

WOCKPHARMA at a glance

  • WOCKPHARMA closed at ₹2,176.4 on 6 Oct 2026, +5.47% on the day, +62.8% over one year, 10.2% below its 52-week high of ₹2,422.3.
  • Delivery was 36.1% of traded quantity on 6 Oct 2026, the 47th percentile of its own 1,731 sessions with a reading (20-session average 34.0%, 1-year average 37.0%).
  • Market capitalisation is ₹35,365 crore at a trailing P/E of 85.4 (trailing EPS ₹25.48).
  • Q1 FY27 results (consolidated, filed 10 Aug 2026): revenue ₹929 crore (+25.9% year on year), net profit ₹107 crore; the price moved -1.1% on the first session after.
  • Promoters held 49.08% at 30 Jun 2026, unchanged on the previous filing, with 14.68% of promoter shares pledged.
  • Q2 FY27 results are expected between 3 Nov 2026 and 14 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE049B01025
SeriesEQ
Listed23 Feb 2000
History from23 Feb 2000
Sessions6,613
Turnover rank#95

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE